Knockout of STAT3 in skeletal muscle does not prevent high-fat diet-induced insulin resistance

Molecular Metabolism

Volumn 4, Issue 8, 2015, Pages 569-575

  White, Amanda T ^a   LaBarge, Samuel A ^a   McCurdy, Carrie E ^b   Schenk, Simon ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF OREGON   (United States)

Author keywords

Clamp; Cre LoxP; Glucose homeostasis; In vivo; Obesity; STAT3

Indexed keywords

CRE RECOMBINASE; CREATINE KINASE; INTERLEUKIN 6; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; ENERGY EXPENDITURE; EPIDIDYMIS FAT; EXON; EXTENSOR DIGITORUM LONGUS MUSCLE; FAT MASS; GASTROCNEMIUS MUSCLE; GENOTYPE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE HOMEOSTASIS; HEART TUMOR; HYPERINSULINEMIA; IMMUNOBLOTTING; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIVER TUMOR; LOXP SITE; MOUSE; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SOLEUS MUSCLE; TIBIALIS ANTERIOR MUSCLE;

CANIS FAMILIARIS; MUS;

EID: 84937738853     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.05.001     Document Type: Article

References (38)

1. Osborn O., Olefsky J.M. The cellular and signaling networks linking the immune system and metabolism in disease. Nature Medicine 2012, 18:363-374.
2. Schenk S., Saberi M., Olefsky J.M. Insulin sensitivity: modulation by nutrients and inflammation. Journal of Clinical Investigation 2008, 118:2992-3002.
3. Du Y., Wei T. Inputs and outputs of insulin receptor. Protein & Cell 2014, 5:203-213.
4. Galic S., Sachithanandan N., Kay T.W., Steinberg G.R. Suppressor of cytokine signalling (SOCS) proteins as guardians of inflammatory responses critical for regulating insulin sensitivity. Biochemical Journal 2014, 461:177-188.
5. Kristiansen O.P., Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent?. Diabetes 2005, 54(Suppl 2):S114-S124.
6. Wunderlich C.M., Hovelmeyer N., Wunderlich F.T. Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity. JAK-STAT 2013, 2:e23878.
7. DeFronzo R.A., Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 2009, 32(Suppl 2):S157-S163.
8. Kim T.H., Choi S.E., Ha E.S., Jung J.G., Han S.J., Kim H.J., et al. IL-6 induction of TLR-4 gene expression via STAT3 has an effect on insulin resistance in human skeletal muscle. Acta Diabetologica 2013, 50:189-200.
9. Mashili F., Chibalin A.V., Krook A., Zierath J.R. Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes. Diabetes 2013, 62:457-465.
10. Jorgensen S.B., O'Neill H.M., Sylow L., Honeyman J., Hewitt K.A., Palanivel R., et al. Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity. Diabetes 2013, 62:56-64.
11. Takeda K., Clausen B.E., Kaisho T., Tsujimura T., Terada N., Forster I., et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999, 10:39-49.
12. Takeda K., Kaisho T., Yoshida N., Takeda J., Kishimoto T., Akira S. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. Journal of Immunology 1998, 161:4652-4660.
13. Nie Y., Erion D.M., Yuan Z., Dietrich M., Shulman G.I., Horvath T.L., et al. STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nature Cell Biology 2009, 11:492-500.
14. Lee Y.S., Li P., Huh J.Y., Hwang I.J., Lu M., Kim J.I., et al. Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes 2011, 60:2474-2483.
15. Turner N., Kowalski G.M., Leslie S.J., Risis S., Yang C., Lee-Young R.S., et al. Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia 2013, 56:1638-1648.
16. Elgazar-Carmon V., Rudich A., Hadad N., Levy R. Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. Journal of Lipid Research 2008, 49:1894-1903.
17. Talukdar S., Oh D.Y., Bandyopadhyay G., Li D., Xu J., McNelis J., et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nature Medicine 2012, 18:1407-1412.
18. Schenk S., McCurdy C.E., Philp A., Chen M.Z., Holliday M.J., Bandyopadhyay G.K., et al. Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction. Journal of Clinical Investigation 2011, 121:4281-4288.
19. White A.T., McCurdy C.E., Philp A., Hamilton D.L., Johnson C.D., Schenk S. Skeletal muscle-specific overexpression of SIRT1 does not enhance whole-body energy expenditure or insulin sensitivity in young mice. Diabetologia 2013, 56:1629-1637.
20. White A.T., Philp A., Fridolfsson H.N., Schilling J.M., Murphy A.N., Hamilton D.L., et al. High-fat diet-induced impairment of skeletal muscle insulin sensitivity is not prevented by SIRT1 overexpression. American Journal of Physiology - Endocrinology and Metabolism 2014, 307:E764-E772.
21. Kim H.J., Higashimori T., Park S.Y., Choi H., Dong J., Kim Y.J., et al. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action invivo. Diabetes 2004, 53:1060-1067.
22. Glund S., Deshmukh A., Long Y.C., Moller T., Koistinen H.A., Caidahl K., et al. Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes 2007, 56:1630-1637.
23. Carey A.L., Steinberg G.R., Macaulay S.L., Thomas W.G., Holmes A.G., Ramm G., et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation invitro via AMP-activated protein kinase. Diabetes 2006, 55:2688-2697.
24. Moh A., Zhang W., Yu S., Wang J., Xu X., Li J., et al. STAT3 sensitizes insulin signaling by negatively regulating glycogen synthase kinase-3 beta. Diabetes 2008, 57:1227-1235.
25. Jiang L.Q., Duque-Guimaraes D.E., Machado U.F., Zierath J.R., Krook A. Altered response of skeletal muscle to IL-6 in type 2 diabetic patients. Diabetes 2013, 62:355-361.
26. Ernst M.B., Wunderlich C.M., Hess S., Paehler M., Mesaros A., Koralov S.B., et al. Enhanced Stat3 activation in POMC neurons provokes negative feedback inhibition of leptin and insulin signaling in obesity. Journal of Neuroscience 2009, 29:11582-11593.
27. Buettner C., Pocai A., Muse E.D., Etgen A.M., Myers M.G., Rossetti L. Critical role of STAT3 in leptin's metabolic actions. Cell Metabolism 2006, 4:49-60.
28. Cernkovich E.R., Deng J., Bond M.C., Combs T.P., Harp J.B. Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity. Endocrinology 2008, 149:1581-1590.
29. Bernier M., Paul R.K., Martin-Montalvo A., Scheibye-Knudsen M., Song S., He H.J., et al. Negative regulation of STAT3 protein-mediated cellular respiration by SIRT1 protein. Journal of Biological Chemistry 2011, 286:19270-19279.
30. Phillips D., Reilley M.J., Aponte A.M., Wang G., Boja E., Gucek M., et al. Stoichiometry of STAT3 and mitochondrial proteins: implications for the regulation of oxidative phosphorylation by protein-protein interactions. Journal of Biological Chemistry 2010, 285:23532-23536.
31. Wegrzyn J., Potla R., Chwae Y.J., Sepuri N.B., Zhang Q., Koeck T., et al. Function of mitochondrial Stat3 in cellular respiration. Science 2009, 323:793-797.
32. Szczepanek K., Chen Q., Larner A.C., Lesnefsky E.J. Cytoprotection by the modulation of mitochondrial electron transport chain: the emerging role of mitochondrial STAT3. Mitochondrion 2012, 12:180-189.
33. Kim J.H., Yoon M.S., Chen J. Signal transducer and activator of transcription 3 (STAT3) mediates amino acid inhibition of insulin signaling through serine 727 phosphorylation. Journal of Biological Chemistry 2009, 284:35425-35432.
34. Inoue H., Ogawa W., Asakawa A., Okamoto Y., Nishizawa A., Matsumoto M., et al. Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metabolism 2006, 3:267-275.
35. Inoue H., Ogawa W., Ozaki M., Haga S., Matsumoto M., Furukawa K., et al. Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism invivo. Nature Medicine 2004, 10:168-174.
36. Reilly S.M., Ahmadian M., Zamarron B.F., Chang L., Uhm M., Poirier B., et al. Asubcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis. Nature Communications 2015, 6:6047.
37. Cui Y., Huang L., Elefteriou F., Yang G., Shelton J.M., Giles J.E., et al. Essential role of STAT3 in body weight and glucose homeostasis. Molecular and Cellular Biology 2004, 24:258-269.
38. Nguyen M.T., Favelyukis S., Nguyen A.K., Reichart D., Scott P.A., Jenn A., et al. Asubpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by FFAS via TLR2, TLR4 and JNK-dependent pathways. Journal of Biological Chemistry 2007, 282:35279-35292.